Cetuximab with lrinotecan/FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomized multicenter AIO phase II study

Document type:: Meeting Abstract
Author(s):: Moehler, M; Trarbach, T; Seufferlein, T; Kubicka, S; Kanzler, S; Lordick, F; Geissler, M; Daum, S; Hoehler, T; Galle, PR
Title:: Cetuximab with lrinotecan/FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomized multicenter AIO phase II study
Journal title abbreviation:: EJC Suppl
Year:: 2007
Journal volume:: 5
Journal issue:: 4
Pages contribution:: 264-264
Language:: eng
Print-ISSN:: 1359-6349
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: